Literature DB >> 9259085

Bladder cancer: natural history, tumor markers, and early detection strategies.

W H Foresman1, E M Messing.   

Abstract

Transitional cell bladder carcinoma is characterized by a dichotomous, multichronotopic natural history. Low and moderate grade Ta lesions frequently recur, yet rarely invade, and carry an excellent prognosis with currently available treatments. High grade Ta lesions, tumors with lamina propria invasion (T1), and carcinoma in situ often progress to invasive disease, at which time overall prognosis is significantly decreased, despite various treatment alternatives. Although early detection of bladder tumors, prior to muscle invasion, should vastly improve our ability to save both bladders and lives, current methods of detection are neither sufficiently sensitive nor specific. Tumor marker analysis is an exciting new frontier in bladder cancer evaluation, and may have important applications to early detection strategies, in combination with simple hematuria testing and other selected noninvasive screening methods.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9259085     DOI: 10.1002/(sici)1098-2388(199709/10)13:5<299::aid-ssu3>3.0.co;2-8

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  10 in total

Review 1.  Recent advances in intravesical drug/gene delivery.

Authors:  Pradeep Tyagi; Pao-Chu Wu; Michael Chancellor; Naoki Yoshimura; Leaf Huang
Journal:  Mol Pharm       Date:  2006 Jul-Aug       Impact factor: 4.939

2.  Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model.

Authors:  P J Grippo; E P Sandgren
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

Review 3.  Use of nomograms as predictive tools in bladder cancer.

Authors:  Ahmad Shabsigh; Bernard H Bochner
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

Review 4.  Molecular screening for bladder cancer: progress and potential.

Authors:  Anirban P Mitra; Richard J Cote
Journal:  Nat Rev Urol       Date:  2010-01       Impact factor: 14.432

5.  Fluorocoxib A loaded nanoparticles enable targeted visualization of cyclooxygenase-2 in inflammation and cancer.

Authors:  Md Jashim Uddin; Thomas A Werfel; Brenda C Crews; Mukesh K Gupta; Taylor E Kavanaugh; Philip J Kingsley; Kelli Boyd; Lawrence J Marnett; Craig L Duvall
Journal:  Biomaterials       Date:  2016-03-21       Impact factor: 12.479

Review 6.  Li-Fraumeni syndrome: cancer risk assessment and clinical management.

Authors:  Kate A McBride; Mandy L Ballinger; Emma Killick; Judy Kirk; Martin H N Tattersall; Rosalind A Eeles; David M Thomas; Gillian Mitchell
Journal:  Nat Rev Clin Oncol       Date:  2014-03-18       Impact factor: 66.675

7.  Preparation and characterization of gelatin-based mucoadhesive nanocomposites as intravesical gene delivery scaffolds.

Authors:  Ching-Wen Liu; Li-Ching Chang; Kai-Jen Lin; Tsan-Jung Yu; Ching-Chung Tsai; Hao-Kuang Wang; Tong-Rong Tsai
Journal:  Biomed Res Int       Date:  2014-12-15       Impact factor: 3.411

Review 8.  Microsatellite Instability Analysis (MSA) for Bladder Cancer: Past History and Future Directions.

Authors:  Chulso Moon; Maxie Gordon; David Moon; Thomas Reynolds
Journal:  Int J Mol Sci       Date:  2021-11-28       Impact factor: 5.923

9.  Bladder cancer detection using electrical impedance technique (tabriz mark 1).

Authors:  Ahmad Keshtkar; Zeinab Salehnia; Asghar Keshtkar; Behrooz Shokouhi
Journal:  Patholog Res Int       Date:  2012-04-09

Review 10.  PSMA-Targeting Positron Emission Agents for Imaging Solid Tumors Other Than Non-Prostate Carcinoma: A Systematic Review.

Authors:  Christophe Van de Wiele; Mike Sathekge; Bart de Spiegeleer; Pieter Jan de Jonghe; Laurence Beels; Alex Maes
Journal:  Int J Mol Sci       Date:  2019-10-02       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.